Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

13%

1 trials in Phase 3/4

Results Transparency

0 of 2 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A

5(71.4%)

Early Phase 1

1(14.3%)

Phase 3

1(14.3%)

7Total

N/A(5)

Early Phase 1(1)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT06525389Phase 3Not Yet Recruiting

Liposomal Amphotericin B and Flucytosine Antifungal Strategy for Talaromycosis (LAmB-FAST)

Role: collaborator

NCT07474883Early Phase 1Recruiting

Efficacy of 0.5% Topical Timolol Eye Drops in the Treatment of Post-Inflammatory Erythema Following Acne Vulgaris

Role: lead

NCT07465744Not ApplicableNot Yet Recruiting

Evaluation of the Support Program to Enhance Self-management Capacity Among Stroke Survivors

Role: lead

NCT07112469Not ApplicableCompleted

The Effectiveness of Intervention to Increase Physical Activity and Sleep Time of Junior High School Students

Role: lead

NCT06444126Recruiting

The Incidence And Risk Factors Of Recurrent Febrile Seizures And Epilepsy Following Febrile Seizures

Role: lead

NCT05207163Not ApplicableUnknown

Continuing Medical Education to Improve Knowledge of Viral Hepatitis B-C in Primary Healthcare Workers

Role: lead

NCT05208333Not ApplicableUnknown

The Effectiveness of Albendazole Treatment Among Infected Toxocara Children

Role: lead

NCT05208320Not ApplicableCompleted

Effectiveness of Community Health Workers in Hypertension Adherence

Role: lead

All 8 trials loaded